Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amoxicillin + clavulanate potassium adverse reaction |
Causative agent (attribute) |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to amoxicillin and clavulanate potassium |
Causative agent (attribute) |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 125mg/31mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amoxiclav 500mg/125mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 400mg/57mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amoxiclav 250mg/125mg s/f dispersible tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 1 gram and clavulanic acid (as clavulanate potassium) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 250mg/62.5mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 200mg/28.5mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 250mg/62.5mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 400mg/57mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amoxiclav 200mg/28.5mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amoxicillin (as amoxicillin trihydrate) 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amoxicillin and clavulanate potassium in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amoxicillin and clavulanate potassium in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amoxiclav 875mg/125mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amoxicillin + clavulanate potassium 600mg/42.9mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
médicament contenant amoxicilline et acide clavulanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amoxycillin with clavulanate potassium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|